ApoGen rakes in $7 mln Series A

Accelerator Corp-based ApoGen Biotechnologies Inc, which develops drugs that treat cancer, has raised $7 million in Series A financing. The investors included AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, Eli Lilly and Company, Johnson & Johnson Innovation – JJDC, Inc, Watson Fund LP, WRF Capital and WuXi PharmaTech.

North AmericaUSBriefs